EIKNEikon Therapeutics Inc. Common Stock
11.39USD-5.16%Mkt Cap: 616.94M $P/E: —3d ago
Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs. Its products include EIK1001, a systemically administered TLR…